L-Lactic Acid

L-Lactic Acid

SCHEMBL32689764

[2H][C@@](C)(O)C(=O)O.[Na]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1SLC9A3

The experimentally established mechanism targets of L-Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
L-Lactic Acid SCHEMBL14726306 0.96
L-Lactic Acid SCHEMBL31675123 0.80
L-Lactic Acid SCHEMBL21957852 0.80
L-Lactic Acid SCHEMBL14122584 0.80
L-Lactic Acid SCHEMBL2338870 0.78
L-Lactic Acid SCHEMBL29701987 0.77
SCHEMBL16945371 0.77
SCHEMBL10791333 0.77
Methylmalonic Acid SCHEMBL14590355 0.74
Lactic Acid SCHEMBL10320998 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4715381-A1 METHOD FOR EVALUATING ONSET RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE, AND BIOMARKERS SHIMADZU CORPORATION (JP) 2026-03-25 EP disclosed